31 related articles for article (PubMed ID: 12765745)
1. Safety and effectiveness of oral medium to high dose blonanserin in patients with schizophrenia: subgroup analysis from a prospective, multicenter, post-marketing surveillance study in mainland China.
Yang Y; Ge H; Wang X; Liu X; Li K; Wang G; Yang X; Deng H; Sun M; Zhang R; Chen J; Cai D; Sang H; Liu X; Zhan G; Zhao G; Li H; Xun Z
Ann Gen Psychiatry; 2023 Oct; 22(1):37. PubMed ID: 37803378
[TBL] [Abstract][Full Text] [Related]
2. Augmentation therapy with serotonin
Yamada R; Wada A; Stickley A; Yokoi Y; Sumiyoshi T
Schizophr Res Cogn; 2023 Dec; 34():100290. PubMed ID: 37732133
[TBL] [Abstract][Full Text] [Related]
3. Effect of 5-HT1A Receptor Partial Agonists of the Azapirone Class as an Add-On Therapy on Psychopathology and Cognition in Schizophrenia: A Systematic Review and Meta-Analysis.
Yamada R; Wada A; Stickley A; Yokoi Y; Sumiyoshi T
Int J Neuropsychopharmacol; 2023 Apr; 26(4):249-258. PubMed ID: 36721972
[TBL] [Abstract][Full Text] [Related]
4. Lurasidone Improves Psychopathology and Cognition in Treatment-Resistant Schizophrenia.
Meltzer HY; Share DB; Jayathilake K; Salomon RM; Lee MA
J Clin Psychopharmacol; 2020; 40(3):240-249. PubMed ID: 32332459
[TBL] [Abstract][Full Text] [Related]
5. Auditing clinical outcomes after introducing off-licence prescribing of atypical antipsychotic melperone for patients with treatment refractory schizophrenia.
Röhricht F; Gadhia S; Alam R; Willis M
ScientificWorldJournal; 2012; 2012():512047. PubMed ID: 22566771
[TBL] [Abstract][Full Text] [Related]
6. Development of orally disintegrating tablets comprising controlled-release multiparticulate beads.
Venkatesh GM; Stevens PJ; Lai JW
Drug Dev Ind Pharm; 2012 Dec; 38(12):1428-40. PubMed ID: 22356215
[TBL] [Abstract][Full Text] [Related]
7. Clinical update on amisulpride in deficit schizophrenia.
Rein W; Turjanski S
Int Clin Psychopharmacol; 1997 May; 12 Suppl 2():S19-27. PubMed ID: 9218164
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacologic approach to negative symptoms in schizophrenia].
Jalenques I
Encephale; 1995 Jun; 21 Spec No 3():35-40. PubMed ID: 7628340
[TBL] [Abstract][Full Text] [Related]
9. Melperone in the treatment of neuroleptic-resistant schizophrenia.
Meltzer HY; Sumiyoshi T; Jayathilake K
Psychiatry Res; 2001 Dec; 105(3):201-9. PubMed ID: 11814539
[TBL] [Abstract][Full Text] [Related]
10. An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder.
Goff DC; Posever T; Herz L; Simmons J; Kletti N; Lapierre K; Wilner KD; Law CG; Ko GN
J Clin Psychopharmacol; 1998 Aug; 18(4):296-304. PubMed ID: 9690695
[TBL] [Abstract][Full Text] [Related]
11. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: results from a randomized, double-blind, placebo-controlled, multicenter, dose-finding study.
Casey DE; Sands EE; Heisterberg J; Yang HM
Psychopharmacology (Berl); 2008 Oct; 200(3):317-31. PubMed ID: 18597078
[TBL] [Abstract][Full Text] [Related]
13. ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. U.S. SEROQUEL Study Group.
Borison RL; Arvanitis LA; Miller BG
J Clin Psychopharmacol; 1996 Apr; 16(2):158-69. PubMed ID: 8690831
[TBL] [Abstract][Full Text] [Related]
14. A comparison of two doses of melperone, an atypical antipsychotic drug, in the treatment of schizophrenia.
Sumiyoshi T; Jayathilake K; Meltzer HY
Schizophr Res; 2003 Jul; 62(1-2):65-72. PubMed ID: 12765745
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
